Advertisement

Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Novo Nordisk

Project type

Insulin and insulin analogue production and purification facilities

Location

Kalundborg, Sweden

Estimated investment

€337m (first phase), €108m (second phase), €100m (third phase)

Completion

2003–04 (first phase), 2005 (second phase), 2006 (third phase)

Sponsor

Novo Nordisk

Contractor

Novo Nordisk Engineering, Ekato Gruppe

Type

Insulin, insulin analogues, Liraglutide

Volume (total)

>40% of worldwide supply
Expand

Free download worth over $5000
Download our 2019 Technology, Media and Telecoms Predictions Report

Worth up to $5,850

In this report, we look at the 30 big tech themes for 2019, identifying winners and losers for each theme. This report will impact all industries helping:

  • CEOs/Senior Staff: in all industries understand the disruptive threats to their competitive landscape
  • Investors: Helps fund managers focus their time on the most interesting investment opportunities in global TM
Close
Close
Close

Go Top